Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2016, Article ID 5029414, 10 pages
http://dx.doi.org/10.1155/2016/5029414
Research Article

A High-Fat, High-Fructose Diet Induces Antioxidant Imbalance and Increases the Risk and Progression of Nonalcoholic Fatty Liver Disease in Mice

1Research Group for Pharmaceutical Activities of Natural Products Using Pharmaceutical Biotechnology (PANPB), Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand
2Faculty of Medicine, Mahasarakham University, Mahasarakham 44000, Thailand

Received 15 December 2015; Accepted 2 February 2016

Academic Editor: Stephen D. H. Malnick

Copyright © 2016 Kanokwan Jarukamjorn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Gaggini, M. Morelli, E. Buzzigoli, R. A. DeFronzo, E. Bugianesi, and A. Gastaldelli, “Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease,” Nutrients, vol. 5, no. 5, pp. 1544–1560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Finelli and G. Tarantino, “Is visceral fat reduction necessary to favour metabolic changes in the liver?” Journal of Gastrointestinal and Liver Diseases, vol. 21, no. 2, pp. 205–208, 2012. View at Google Scholar · View at Scopus
  3. G. Tarantino, C. Finelli, A. Colao et al., “Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?” Journal of Translational Medicine, vol. 10, article 50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. D. Browning, L. S. Szczepaniak, R. Dobbins et al., “Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity,” Hepatology, vol. 40, no. 6, pp. 1387–1395, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. P. Day, “Pathogenesis of steatohepatitis,” Best Practice & Research Clinical Gastroenterology, vol. 16, pp. 663–678, 2002. View at Google Scholar
  6. S. Abiru, K. Migita, Y. Maeda et al., “Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis,” Liver International, vol. 26, no. 1, pp. 39–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. R. D. Situnayake, B. J. Crump, D. I. Thurnham, J. A. Davies, J. Gearty, and M. Davis, “Lipid peroxidation and hepatic antioxidants in alcoholic liver disease,” Gut, vol. 31, no. 11, pp. 1311–1317, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Wang, W. Zhou, B. Wang, H. Zhu, L. Ye, and M. Feng, “Antioxidant effect of apolipoprotein A-I on high-fat diet-induced non-alcoholic fatty liver disease in rabbits,” Acta Biochimica et Biophysica Sinica, vol. 45, no. 2, pp. 95–103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. F. A. Anania, “Non-alcoholic fatty liver disease and fructose: bad for us, better for mice,” Journal of Hepatology, vol. 55, no. 1, pp. 218–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. B. Vos and J. E. Lavine, “Dietary fructose in nonalcoholic fatty liver disease,” Hepatology, vol. 57, no. 6, pp. 2525–2531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Yilmaz, “Review article: fructose in non-alcoholic fatty liver disease,” Alimentary Pharmacology and Therapeutics, vol. 35, no. 10, pp. 1135–1144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Charlton, A. Krishnan, K. Viker et al., “Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 301, pp. G825–G834, 2011. View at Google Scholar
  13. A. Ibrahim, S. Natarajan, and Ghafoorunissa, “Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats,” Metabolism: Clinical and Experimental, vol. 54, no. 2, pp. 240–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. L. van Dommelen, A. Rizzitelli, A. Chidgey, R. Boyd, K. Shortman, and L. Wu, “Regeneration of dendritic cells in aged mice,” Cellular and Molecular Immunology, vol. 7, no. 2, pp. 108–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Jearapong, W. Chatuphonprasert, and K. Jarukamjorn, “Effect of tetrahydrocurcumin on the profiles of drug-metabolizing enzymes induced by a high fat and high fructose diet in mice,” Chemico-Biological Interactions, vol. 239, pp. 67–75, 2015. View at Publisher · View at Google Scholar
  16. K. Jarukamjorn, T. Sakuma, J.-I. Miyaura, and N. Nemoto, “Different regulation of the expression of mouse hepatic cytochrome P450 2B enzymes by glucocorticoid and phenobarbital,” Archives of Biochemistry and Biophysics, vol. 369, no. 1, pp. 89–99, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Chatuphonprasert, L. Udomsuk, O. Monthakantirat, Y. Churikhit, W. Putalun, and K. Jarukamjorn, “Effects of Pueraria mirifica and miroestrol on the antioxidation-related enzymes in ovariectomized mice,” Journal of Pharmacy and Pharmacology, vol. 65, no. 3, pp. 447–456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Lao-Ong, W. Chatuphonprasert, N. Nemoto, and K. Jarukamjorn, “Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine,” Pharmaceutical Biology, vol. 50, no. 8, pp. 1007–1012, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Kondo, W. Chatuphonprasert, A. Jaruchotikamol, T. Sakuma, and N. Nemoto, “Cellular glutathione content modulates the effect of andrographolide on β-naphthoflavone-induced CYP1A1 mRNA expression in mouse hepatocytes,” Toxicology, vol. 280, no. 1-2, pp. 18–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. T. Timlin and E. J. Parks, “Temporal pattern of de novo lipogenesis in the postprandial state in healthy men,” American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 35–42, 2005. View at Google Scholar · View at Scopus
  21. A. M. Zivkovic, J. B. German, and A. J. Sanyal, “Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease,” American Journal of Clinical Nutrition, vol. 86, no. 2, pp. 285–300, 2007. View at Google Scholar · View at Scopus
  22. C. Loguercio, G. Nardone, P. Sicolo, R. Cuomo, C. Del Vecchio Blanco, and G. Budillon, “Intravenous load of fructose and fructose 1,6-diphosphate: effects on uricemia in patients with nonalcoholic liver disease,” American Journal of Gastroenterology, vol. 91, no. 3, pp. 559–564, 1996. View at Google Scholar · View at Scopus
  23. E. E. Kershaw and J. S. Flier, “Adipose tissue as an endocrine organ,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe, “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1784–1792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. C. Cazanave, N. A. Elmi, Y. Akazawa, S. F. Bronk, J. L. Mott, and G. J. Gores, “CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 299, no. 1, pp. G236–G243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. S. Winzell and B. Ahrén, “The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes,” Diabetes, vol. 53, supplement 3, pp. S215–S219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. L. H. Tetri, M. Basaranoglu, E. M. Brunt, L. M. Yerian, and B. A. Neuschwander-Tetri, “Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 295, no. 5, pp. G987–G995, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C. S. Lieber, M. A. Leo, K. M. Mak et al., “Model of nonalcoholic steatohepatitis,” The American Journal of Clinical Nutrition, vol. 79, no. 3, pp. 502–509, 2004. View at Google Scholar · View at Scopus
  29. Y. Zou, J. Li, C. Lu et al., “High-fat emulsion-induced rat model of nonalcoholic steatohepatitis,” Life Sciences, vol. 79, no. 11, pp. 1100–1107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. C. P. Day and O. F. W. James, “Steatohepatitis: a tale of two ‘Hits’?” Gastroenterology, vol. 114, no. 4, pp. 842–845, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Sanyal, C. Campbell-Sargent, F. Mirshahi et al., “Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities,” Gastroenterology, vol. 120, no. 5, pp. 1183–1192, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. I. A. Leclercq, G. C. Farrell, J. Field, D. R. Bell, F. J. Gonzalez, and G. R. Robertson, “CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis,” The Journal of Clinical Investigation, vol. 105, no. 8, pp. 1067–1075, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. J. W. Baynes, “Role of oxidative stress in development of complications in diabetes,” Diabetes, vol. 40, no. 4, pp. 405–412, 1991. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Kumar, A. Sharma, A. Duseja et al., “Patients with nonalcoholic fatty liver disease (NAFLD) have higher oxidative stress in comparison to chronic viral hepatitis,” Journal of Clinical and Experimental Hepatology, vol. 3, no. 1, pp. 12–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Zitka, S. Skalickova, J. Gumulec et al., “Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients,” Oncology Letters, vol. 4, no. 6, pp. 1247–1253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J. N. Dhuley, “Anti-oxidant effects of cinnamon (Cinnamomum verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet,” Indian Journal of Experimental Biology, vol. 37, no. 3, pp. 238–242, 1999. View at Google Scholar · View at Scopus
  37. R. Polavarapu, D. R. Spitz, J. E. Sim et al., “Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil,” Hepatology, vol. 27, no. 5, pp. 1317–1323, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Chance, H. Sies, and A. Boveris, “Hydroperoxide metabolism in mammalian organs,” Physiological Reviews, vol. 59, no. 3, pp. 527–605, 1979. View at Google Scholar · View at Scopus